Carl Kraus
Chief Tech/Sci/R&D Officer at AQUESTIVE THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Carl N.
Kraus was the founder of Arrevus, Inc. founded in 2015, where he held the titles of Chairman, President & Chief Executive Officer from 2017 to 2021.
Currently, he is the Medical Director at i3 Research, Inc. and the Chief Medical Officer at Aquestive Therapeutics, Inc. since 2023.
Previously, he served as the Chief Medical Officer at Idera Pharmaceuticals, Inc. and Resilience Government Services, Inc. He was also the Chief Medical Officer at Aceragen, Inc. from 2021 to 2023.
Dr. Kraus received his undergraduate degree from Washington University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-06 | 262,500 ( 0.29% ) | 1 M $ | 2024-04-29 | |
ACERAGEN, INC.
-.--% | 2023-01-16 | 0 ( -.--% ) | - $ | 2023-07-30 |
Carl Kraus active positions
| Companies | Position | Start |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-06-25 |
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Chief Tech/Sci/R&D Officer | - |
Former positions of Carl Kraus
| Companies | Position | End |
|---|---|---|
| ACERAGEN, INC. | Chief Tech/Sci/R&D Officer | 2023-04-29 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Chief Executive Officer | 2021-10-30 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Chief Tech/Sci/R&D Officer | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Chief Tech/Sci/R&D Officer | - |
Training of Carl Kraus
| Washington University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ACERAGEN, INC. | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Carl Kraus